Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Prednisone in Advanced Hormone Refractory Prostate Cancer
NCT00280098Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of docetaxel in prostate cancer (PCa), sponsored by Sanofi. Started Jan 2006; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00280098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280098.